SOUTHAMPTON, Pa., Dec. 8 /PRNewswire-FirstCall/ -- Environmental Tectonics Corporation's (Amex: ETC) ("ETC" or the "Company") BioMedical Division today announced the recent installation of two BARA-MED(R)XD Monoplace hyperbaric oxygen chambers in the St. John Wound Center, Tulsa, Oklahoma, USA. The state-of-the-art monoplace chambers are the first computer-controlled hyperbaric chambers to be placed into service in Oklahoma.

Hyperbaric oxygen (HBO) chambers offer advanced care for chronic wounds by administering pure oxygen under increased atmospheric pressure, which speeds and enhances the body's natural ability to heal. This allows for an increased amount of oxygen to be carried by the blood system, offering multiple benefits to the organs and tissues of the body. Additionally, HBO improves the benefit of certain antibiotics, activates white blood cells and promotes the healing process in chronic wounds.

St. John Health System operates hospitals in Tulsa, Owasso, Sapulpa and Bartlesville. A fifth affiliate hospital is under construction in Broken Arrow, Okla., with completion scheduled for 2010.

"The staff of the St. John Wound Center is committed to the treatment of the whole patient, not just the wound," said Dr. Lam Le, Medical Director of the St. John Wound Center. "We work closely with specialists and primary care physicians to provide a complete care plan for optimal wound healing to address the specific needs of each patient."

Dr. Le noted that individuals with slow healing or chronic wounds may be candidates for wound therapy. Chronic wounds are characterized by tissue that does not heal in a timely manner, usually between two to four weeks.

ETC manufactures the industry's most technically advanced hyperbaric chamber. The BARA-MED(R) XD includes a 4th generation computer based operating system which controls and records chamber activity. ETC chambers continue to remain the leader in providing a patient friendly pressurization alternative (Smooth Ride(TM)) that minimizes complications due to middle ear and sinus barotraumas without increasing compression time.

Gene Davis, President of ETC's BioMedical Division, commented, "With placement of these chambers in Oklahoma, we are seeing an increased footprint of sales growth in the Southern United States."

ETC is witnessing an increased demand from hospitals and wound care clinics that recognize that our chambers are ready to meet the demands of EMR (Electronic Medical Records). ETC plans to continue to supply our customers with most well-designed and scientifically advanced products in a competitive market.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on ETC's current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ETC and its subsidiaries that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

These forward-looking statements include statements with respect to the Company's vision, mission, strategies, goals, beliefs, plans, objectives, expectations, anticipations, estimates, intentions, financial condition, results of operations, future performance and business of the company, including but not limited to, (i) potential additional funding by Lenfest, (ii) the potential delisting of the Company's common stock from the American Stock Exchange as a result of the Company's failure to comply with the AMEX listing standards, (iii) projections of revenues, costs of materials, income or loss, earnings or loss per share, capital expenditures, growth prospects, dividends, capital structure, other financial items and the effects of currency fluctuations, (iv) statements of our plans and objectives of the Company or its management or Board of Directors, including the introduction of new products, or estimates or predictions of actions of customers, suppliers, competitors or regulatory authorities, (v) statements of future economic performance, (vi) statements of assumptions and other statements about the Company or its business, (vii) statements made about the possible outcomes of litigation involving the Company, including our outstanding litigation with Disney; (viii) statements regarding the Company's ability to obtain financing to support its operations and other expenses, and (ix) statements preceded by, followed by or that include the words, "may," "could," "should," "looking forward," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan," or the negative of such terms or similar expressions. These forward-looking statements involve risks and uncertainties which are subject to change based on various important factors. Some of these risks and uncertainties, in whole or in part, are beyond the Company's control. Factors that might cause or contribute to such a material difference include, but are not limited to, those discussed in the Company's Annual Report on Form 10K for the fiscal year ended February 29, 2008, in the section entitled "Risks Particular to Our Business." Shareholders are urged to review these risks carefully prior to making an investment in the Company's common stock. The Company cautions that the foregoing list of important factors is not exclusive. Except as required by federal securities law, the Company does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company.

(Date:10/11/2017)... ... October 11, 2017 , ... A new ... rates in frozen and fresh in vitro fertilization (IVF) transfer cycles. ... to IVF success. , After comparing the results from the fresh and frozen ...

(Date:10/10/2017)... ... October 10, 2017 , ... For the second ... a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled to Washington, ... from US2020. , US2020’s mission is to change the trajectory of STEM education ...

(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...

(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...